Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 10, 2020 07:00 ET | Source: RedHill Biopharma Ltd.

RedHill Biopharma to Present at the Barclays Global Healthcare Conference

TEL-AVIV, Israel and RALEIGH, N.C., March 10, 2020 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company focused on...
March 09, 2020 07:00 ET | Source: RedHill Biopharma Ltd.

RedHill Biopharma Announces U.S. Commercial Launch of Talicia® for H. pylori Infection

Talicia® is the first and only FDA-approved rifabutin-based therapy for treatment of H. pylori infection designed as a first-line option to address the high and growing H. pylori resistance to...
March 09, 2020 06:00 ET | Source: CytoDyn Inc.

CytoDyn Files IND and Protocol for Phase 2 Clinical Trial for Treatment of Coronavirus Patients with Leronlimab (PRO 140)

Coronavirus Can Quickly Progress to Severe Pneumonia and Even Death Due to Immune Hyperactivity Including Acute Respiratory Distress Syndrome (ARDS); CytoDyn's Trial Focuses on Patients Who Develop...
March 08, 2020 17:52 ET | Source: CytoDyn Inc.

CytoDyn Files IND and Protocol for Phase 2 Clinical Trial for Treatment of Patients with Coronavirus with Leronlimab (PRO 140)

Coronavirus Can Quickly Progress to Severe Pneumonia and Even Death Due to Immune Hyperactivity Including Acute Respiratory Distress Syndrome (ARDS); CytoDyn's Trial Focuses on Patients Who Develop...
March 06, 2020 21:09 ET | Source: Trupanion

UPDATE: Despite Ongoing News of International "Weak Positive" Reports, Trupanion Continues to Find No Indications that Pets are Negatively Impacted by a Coronavirus Outbreak

SEATTLE, March 06, 2020 (GLOBE NEWSWIRE) -- Ongoing reports from Hong Kong authorities regarding a lone dog that tested as a “weak positive” for the coronavirus COVID-19, continue to generate...
March 06, 2020 07:30 ET | Source: Neuronetics

FDA Grants NeuroStar® Advanced Therapy System Breakthrough Device Designation to Treat Bipolar Depression

MALVERN, Pa., March 06, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
March 05, 2020 08:30 ET | Source: Champignon Brands Inc.

Champignon Brands Spotlighted in Publication Discussing Mushrooms in Medicine

NEW YORK, March 05, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Champignon Brands Inc. (CSE:SHRM) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 40+...
March 04, 2020 19:00 ET | Source: Radient Technologies Inc

Radient Technologies Inc. Receives License Amendment from Health Canada for its Edmonton II Facility and Closes First Tranche of its Previously Announced Debenture Financing

EDMONTON, Alberta, March 04, 2020 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality...
March 04, 2020 07:52 ET | Source: BioSig Technologies, Inc.

BioSig Appoints John W. Osborn, Ph.D. as Consultant on Autonomic Neuromodulation

Westport, CT, March 04, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal...
March 04, 2020 07:00 ET | Source: RedHill Biopharma Ltd.

RedHill Biopharma Provides Full-Year 2019 Financial Results and Operational Highlights

Key Highlights: Talicia® approved by the FDA for the treatment of H. pylori infection in adults; U.S. launch with RedHill’s sales force expected by mid-March 2020 Acquisition of global rights to...